SS
RLYB icon

SBI Securities’s Rallybio RLYB Stock Holding History

SBI Securities’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.7K Sell
524
-7
-1% -$48 ﹤0.01% 2054
2025
Q4 		$2.92K Hold
531
– – ﹤0.01% 2250
2025
Q3 		$2.12K Sell
531
-25
-4% -$105 ﹤0.01% 2396
2025
Q2 		$1.5K Sell
556
-5
-0.9% -$13 ﹤0.01% 2511
2025
Q1 		$2.94K Sell
561
-109
-16% -$689 ﹤0.01% 2129
2024
Q4 		$5.14K Buy
+670
New +$5.61K ﹤0.01% 1912

Other funds holding RLYB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

SBI Securities's RLYB Position: Q1 2026 in Review

SBI Securities reduced its Rallybio (RLYB) stake by 1.3% in Q1 2026, selling an estimated $48 and leaving 524 shares worth $4.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2054.

SBI Securities first reported a position in RLYB in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.14K in Q4 2024. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • SBI Securities held 524 shares of Rallybio worth $4.7K as of Q1 2026.
  • SBI Securities sold 7 Rallybio shares in Q1 2026, an estimated $48.
  • Rallybio made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2054 holding.
  • SBI Securities first reported a position in Rallybio in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Rallybio position peaked at $5.14K in Q4 2024.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.